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Abstract Objective: Several studies
demonstrated that the lungs could
produce lactate in patients with acute
lung injury (ALI). Because after car-
diopulmonary bypass (CPB) some
patients develop ALI, the effect of
CPB on pulmonary lactate release
was investigated. Design: Prospec-
tive observational clinical study.
Setting: Twenty-beds, surgical ICU at
a university hospital. Patients: Six-
teen deeply sedated, ventilated and
post-cardiac surgery patients, all
equipped with a pulmonary artery
catheter. Measurements and results:
Lactate concentration was measured
using a lactate analyser in simulta-
neously drawn arterial (A) and mixed
venous (V) blood samples. Three
measurements per patients were tak-
en at 30-min interval, after body
temperature reached 37C. Con-
comitantly, measurements of cardiac
output were also obtained. Pulmonary
lactate release was calculated as the
product of transpulmonary A-V lac-
tate and cardiac index. The mean
cardiopulmonary bypass duration was
100€44 min (SD), and the aortic
cross-clamping time was 71€33 min.
After CPB, lactate release was
0.136€0.210 mmol/min m2. These
values were not correlated with car-
diopulmonary bypass duration.
Conclusion: The present study shows
that in patients receiving mechanical
ventilation after CPB, the lung is a
source of lactate production. This
pulmonary release was not dependent
on cardiopulmonary bypass duration.
Keywords Extracorporeal
circulation · Respiratory failure ·
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Introduction
Pulmonary dysfunction related to acute lung injury (ALI)
is one of the complications observed after heart surgery
using cardiopulmonary bypass (CPB) [1]. Despite the
uncertainty on the exact pathophysiological mechanism
leading to post CBP ALI [2], the occurrence of a
postoperative hypoxaemic condition has been attributed
to a post CPB-systemic inflammatory response syndrome
[3].
In patients with ALI and/or adult respiratory distress
syndrome, several studies have demonstrated that lactate
is released by the lung [4, 5, 6, 7]. Likewise, we have
observed that the arterial lactate concentration in the
systemic circulation was higher than in the pulmonary
artery mixed venous blood in patients after CPB; thus, we
hypothesised that during CPB the lung could be a source
of lactate production when lung parenchyma has been
hypoperfused during extracorporeal circulation.
Based on these observations and hypothesis, the
present study was carried out to prospectively investigate,
firstly, if a lactate release from the lungs occurs during the
early postoperative course after hypothermic CPB, and
secondly to determine whether a relationship exists
between pulmonary lactate flux and CPB time and/or
hypoxaemia [8].
818
Methods
Our institutional ethical committee approved the study, and all
patients gave written consent the day before surgery. Patients
scheduled for CABG surgery were prospectively screened. Exclu-
sion criteria were: decreased pre-operative left ventricular ejection
fraction (<45% assessed by echocardiography, isotopic or angio-
graphic ventriculography), valve disease, other associated cardiac
surgery and/or history of chronic respiratory disease. Post-opera-
tively, patients presenting with haemodynamic instability and
bleeding greater than 100 ml/h were also excluded.
Perioperative management
Anti-anginal therapy was discontinued the evening before surgery
but per-oral metoprolol was given to patients receiving chronic b-
adrenergic blocker therapy. One hour prior to surgery, diazepam
and morphine pre-medication were administrated. A 20-G radial
artery catheter and a flow-directed modified pulmonary artery
catheter capable of continuous monitoring mixed venous oxygen
saturation (SVO2; Vigilance Monitor, Baxter Edwards, Irvine,
Calif.) were inserted for clinical purpose. Anaesthesia and muscle
relaxation were induced and maintained with midazolam, fentanyl
and pancuronium bromide. The patient’s trachea was intubated
with an endotracheal tube. A nasogastric tube and a Foley urinary
catheter were also inserted. Hypothermic (28C) cardiopulmonary
bypass and cold cardioplegic-induced cardiac arrest were used. The
cardiopulmonary bypass flow was set at 2 l min1 m2 and mean
arterial pressure was maintained at 60 mm Hg using vasoactive
drugs, as necessary. During cardiopulmonary bypass the lungs were
not ventilated but inflated with a continuous positive airway
pressure of 2–5 cm H2O. Weaning from cardiopulmonary bypass
was achieved with inotropic or vasopressor drug support when
required. After surgery, patients were transferred to the surgical
intensive care unit. Upon arrival, sedation and analgesia were
provided by continuous infusion of midazolam and morphine. The
patients were placed on mechanical ventilation (Evita4, Drger,
Lbeck, Germany). Initial ventilator settings in controlled mechan-
ical ventilation (CMV) mode were: tidal volume (8–10 ml kg1 of
body weight) and respiratory rate (12 breath min1). The targets for
arterial pH and PaCO2 were at 7.40 and 5 kPa, respectively. The
inspired oxygen fraction (FiO2) was adjusted to obtain an arterial
oxygen saturation (SaO2) >92%. Inspiratory to expiratory ratio
(I/E) was 1/2. No positive end-expiratory pressure (PEEP) was
used. Body temperature, lead II ECG and urine output were
monitored throughout the postoperative period. Patients were
wrapped with warm blankets to restore normal temperature. The
patients were observed for at least 2 h to confirm haemodynamic
stability, which was defined as less than 10% variation in haemo-
dynamic variables [heart rate, cardiac output (CO) and mixed
venous oxygen saturation (SVO2) continuous monitoring, mean
arterial pressure], no clinically relevant bleeding (<100 ml/h) and
normal body temperature. A chest radiograph was obtained prior to
data collection to define the correct position of the pulmonary
artery and central venous catheters, the position of the surgical
drains, and also to confirm the absence of cardiopulmonary
abnormalities (grossly enlarged mediastinal silhouette, pleural
effusion or pneumothorax). A 12-lead ECG was also recorded to
verify a regular sinus rhythm. Body position changes, patient care
and endotracheal suctioning, if required, were allowed during this
period but not during the study protocol. All patients received a
continuous intravenous infusion of NaCl 0.9% at rate of 65 ml/h.
Haemodynamic monitoring
All pressure transducers were referenced to mid-chest. The correct
position of the catheter tip in West’s zone 3 was checked using the
method described by Teboul et al. [9]. SvO2 was calibrated in vivo
according to the manufacturer’s instruction by simultaneous mea-
surements of mixed-venous blood on a co-oxymeter (Statprofile
Ultra, Nova biomedical, Waltham, Mass.). Mean cardiac output
(CO) was estimated by averaging triplicate injections of 10 ml
room temperature 0.9% NaCl, delivered randomly during the
respiratory cycle, and used to calculate the cardiac index (CI).
Study protocol
During the study protocol, all patients were receiving IV sedation
and were not breathing spontaneously. Patients were kept in the
supine position. If patients were receiving vasoactive drugs, the
administration rate was not changed during the protocol. Three
measurements of the following variables were recorded at 30-min
intervals in each patient, from the bedside monitor (Agilent
technologies M3150A) and Vigilance Monitor (Baxter Edwards,
Irvine, Calif.): body temperature; continuous SvO2; continuous CO;
mean CO; heart rate; calculated stroke volume; systolic, diastolic
and mean arterial and pulmonary arterial pressures; right atrial
pressure; and pulmonary artery occlusion pressure. Ventilator
settings (respiratory rate, tidal volume, I/E, FiO2, PEEP), peak and
mean airway pressures were recorded. The acute lung injury score
proposed by Murray et al. was calculated [8].
Lactate measurements
Two blood samples were simultaneously drawn: one from the radial
artery catheter and one from the distal port of the pulmonary artery
catheter. After discarding the first 3 ml of blood from each sample,
arterial and mixed venous blood gases, as well as arterial and mixed
venous lactate, were analysed in 2.5-ml samples at 37C (Statpro-
file Ultra, Nova biomedical, Waltham, Mass.). Pulmonary lactate
release (LR) was calculated using the following formula: (arterial
lactate-venous lactate)  CI [4]. Three measurements were done
over 90 min in each patient, many hours after the end of the
cardiopulmonary bypass, after rectal temperature reached 37C.
Statistical analysis
The study was designed to detect a mean arterial-venous difference
under the alternative hypothesis of 0.05, with a standard deviation
of 0.07 based on data from by Routsi et al. [7], and assuming zero
difference in arterial and venous lactate under the null hypothesis.
Accordingly, the sample size was 16 patients to detect this
difference, using a two-sided alpha level of 0.05 and a b-power of
0.8.
All values are expressed as mean€standard deviation (SD). For
variables that were measured repeatedly, the mean was calculated
using the average over all the measures taken in the same subject,
so that each individual only contributed one observation. A two-
tailed paired t test was used to compare mixed venous and arterial
lactate measurements, cross-sectionally at each time (between
subject difference), while ANOVA was used to compare arterial
and mixed venous measures longitudinally (within-subject differ-
ence). To account for dependence in the data due to repeated
measures, regression coefficients for the relationship between
pulmonary lactate release and CPB time or the ratio of PaO2 to
inspired oxygen fraction (PaO2/FiO2) were obtained using gener-
alised estimating equations (GEE), with robust estimates of the
variance [10, 11]. Statistical analyses were run using STATA
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(version 7.0; Stata Corporation, Texas). A value of p<0.05 was
considered statistically significant.
Results
Sixteen patients were included in the study. Demographic
and preoperative characteristics are presented in Table 1.
The mean cardiopulmonary bypass duration was
100€44 min and the aortic cross-clamp time was
71€33 min. Six patients required catecholamines infusion
(37%) with no change in dose during the protocol. Mean
ratio of PaO2/FiO2 was 48.8€7 kPa. Mean acute lung
injury score (ALI score) was 1.9€0.2. Mean cardiac index
was 2.8€0.2 l min–1 m–2.
Mean arterial pH was significantly higher than mean
mixed venous pH, 7.38€0.03 vs 7.35€0.03 (p<0.01),
respectively. Mean arterial lactate concentration was
higher than mean mixed venous lactate concentration,
0.83€0.2 vs 0.78€0.17 mmol/l (p=0.028; Fig. 1). Mean
LR was 0.136€0.2 mmol min1 m2 after CPB (Table 2).
There was a suggestion that a higher pulmonary lactate
release was associated with a lower PaO2/FiO2 ratio [b-
coefficient=50.53 (95% CI: 107.78, 6.71); p=0.084;
Fig. 2]. There was no relationship between cardiopulmo-
nary bypass duration and pulmonary lactate release
(p=NS). Moreover, pulmonary lactate release was not
correlated to mixed venous oxygen saturation (p=NS)
Discussion
The main finding of this study is that following CPB the
lungs release lactate into the systemic circulation. More-
over, lung lactate production is not correlated with CPB
time and mixed venous saturation, but it tends to be
associated with the degree of pulmonary dysfunction, as
indicated by the degree of hypoxaemia.
Routsi et al. [7] found that mixed-venous lactate
concentration was higher than arterial lactate concentra-
tion in patients without ALI and did not undergo CPB;
thus, in the absence of ALI, the lung does not produce
lactate. To explore the difference between patients with-
out respiratory failure or ALI and those post CPB, we
compared our data with those by Routsi et al. [7] (ex-
ternal control; assuming an underlying t distribution
with unequal variances [10, 11]). The mean pulmo-
nary lactate release obtained in the present study was
0.136€0.2 mmol min1 m2, whereas it was 0.038€
0.065 mmol min1 m2 in the study by Routsi et al. [7],
providing a mean difference of 0.17 (95% CI: 0.061,
0.287; p<0.01). This finding suggests that after CPB even
a mild degree of lung dysfunction (hypoxaemia) is
associated with pulmonary lactate release.
In the present study, we speculated that the lactate
production by the lung was related to the hypoperfused or
hypoxic lung tissue producing lactic acidosis; however,
the absence of acidosis and the higher systemic arterial
pH strongly challenges this hypothesis. Moreover, lung
lactate production (which tended to increase over time;
Fig. 1) was not correlated with CPB time but inversely
correlated with PaO2/FiO2 suggesting a different mech-
Table 1 Patients demographic characteristics. LVEF left ventricu-
lar ejection fraction, CABG number of coronary artery bypass
grafts, CPB cardiopulmonary bypass
Patient
no.
Age Gender LVEF CABG CPB
(years) (%) Time (min)
1 66 F 80 3 148
2 68 F 70 3 150
3 56 M 55 2 60
4 75 M 55 2 70
5 71 F 62 1 50
6 68 M 65 3 95
7 59 M 53 1 65
8 64 F 70 1 50
9 62 M 67 3 140
10 53 M 52 2 50
11 53 M 45 2 67
12 52 M 60 3 117
13 60 M 74 3 120
14 63 M 75 4 190
15 81 F 71 2 90
16 68 M 60 4 137
Mean€SD 63€8 63€10 2.4€0.9 100€44
Fig. 1A,B Box-and-whiskers
plot displaying arterial (A) and
venous (B) lactate (median, in-
terquartile range) measured ev-
ery 30 min (T1, T2, T3) after
rewarming, in 16 patients after
hypothermic cardiopulmonary
bypass surgery. A trend in ar-
terial, but not venous, lactate
concentration increase was ob-
served over time
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anism of lung lactate production; the latter could be
secondary to a systemic inflammatory response induced
by CBP [12] and/or surgical trauma (e.g. opening chest)
[13] without detectable lung tissue hypoxia. Indeed,
cardiac surgery without CPB may also disturbs the
respiratory mechanics, as emphasised in a recent work
by Roosens et al. [13].
In contrast with the results of the present study, Loer
and colleagues [14] showed no evidence of lung isch-
aemia and/or pulmonary lactate release in patients during
hypothermic CPB. The difference between the present
study and Loer et al. [14] study could be attributed to a
different design. Those authors measure lactate release
during the hypothermic stage of CPB. The lung protective
condition with hypothermia, in this study, might have
disappeared after rewarming. Moreover, there is no
reference to experimental models of ALI following aortic
cross-clamping and during CPB pulmonary artery blood
flow is completed inhibited so that the lungs are perfused
solely via bronchial artery; thus, we may expect that lung
ischaemia may have occurred and that optimal oxygen-
ation under mechanical ventilation after the end of CPB
may have participated in a post-reperfusion lung injury
[1]. In the absence of pyruvate measurements (ratio
Table 2 Respiratory variables and blood lactate concentration. CT static compliance of the respiratory system, CI cardiac index, VL mixed
venous lactate, AL arterial lactate, L (A-V) arterio-venous lactate gradient, LR lactate release, SvO2 mixed venous oxygen saturation
Patient
no.
PaO2/FiO2 ALI score CT CI SvO2 pH PaCO2 VL AL L (A-V) LR
(kPa) (ml/cm
H2O1)
(l/min
m2)
(%) (kPa) mmol/l mmol/l mmol/l mmol/min
m2
1 59 2.0 32.5 2.7 75 7.42 4.6 1.033 1.067 0.033 0.090
2 44 2.0 40.1 2.7 68 7.34 5.2 0.933 1.000 0.067 0.178
3 48 1.7 45.8 3.3 74 7.38 5.4 0.633 0.633 0.000 0.000
4 50 1.7 48.9 2.8 71 7.36 4.9 0.633 0.700 0.067 0.186
5 61 1.7 45.1 2.6 72 7.38 4.4 0.700 0.667 -0.033 -0.086
6 55 2.0 39.5 2.8 59 7.36 4.9 0.800 0.867 0.067 0.187
7 57 1.7 44.6 2.4 68 7.38 5.5 0.900 0.767 -0.133 -0.324
8 43 2.0 58.7 2.7 71 7.33 6.1 0.700 0.833 0.133 0.361
9 50 1.7 36.6 2.8 71 7.37 4.7 0.967 1.033 0.067 0.186
10 49 2.0 28.3 2.7 59 7.43 4.8 1.100 1.333 0.233 0.636
11 50 2.0 37.2 2.8 72 7.4 5.4 0.667 0.733 0.067 0.186
12 35 2.3 35.2 3.0 55 7.43 4.8 0.633 0.733 0.100 0.302
13 39 2.0 43.5 3.0 68 7.38 5 0.767 0.767 0.000 0.000
14 46 2.0 33.1 3.2 60 7.39 4.9 0.767 0.800 0.033 0.107
15 48 2.0 31.7 2.6 73 7.4 4 0.767 0.767 0.000 0.000
16 44 2.3 39.5 2.5 69 7.35 5.3 0.467 0.533 0.067 0.168
Mean€SD 49€7 1.9€0.2 40€7 2.8€0.2 68€6 7.38€
0.03
5€0.5 0.779€
0.169
0.827€
0.197
0.048€
0.079
0.136€
0.210
Fig. 2 Plot displaying the mean
PaO2/FiO2 ratio vs lung lactate
release (LR), in 16 patients after
hypothermic cardiopulmonary
bypass surgery. From the re-
gression model, the b-coeffi-
cient was 50.53 (95% CI:
107.78, 6.71; p=0.084)
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lactate/pyruvate), it is difficult to ascertain the pathogen-
esis of this lactate production by the lung. Indeed, the
study design did not allow us to determine the mecha-
nisms of transpulmonary lactate gradient or the mecha-
nisms underlying the link between pulmonary lactate
production and the degree of hypoxaemia.
Some limitations of this work should be acknowl-
edged. Firstly, in view of the small difference between
arterial and venous blood lactate concentrations, its
clinical relevance could be questioned. Nevertheless,
several studies showed a small error in lactate measure-
ment in critically ill patients and validated the accuracy of
lactate flux calculation [5, 7, 15].
Secondly, arterial lactate blood samples were drawn
from the radial catheter and not from pulmonary vein or
the left atrium. Indeed, peripheral arterial lactate concen-
tration could be different from arterial lactate drawn
proximal to the lung (pulmonary venous); however,
several studies investigating lung lactate production have
used a similar methodology and found the same values at
both locations [5, 6, 7, 15]. Finally, our sample size was
small and ALI occurred in few patients, thus hampering
the possibility of explaining lung lactate production via
the development of clinically relevant lung damage.
Conclusion
In conclusion, the present study is the first to demonstrate
the occurrence of lung lactate production after CPB, as
indicated by a positive arterio-venous lactate difference,
in patient without history of pulmonary disease; however,
further studies are needed to investigate the nature of the
relationship between lung lactate release and lung injury
or lung tissue hypoxia in patients undergoing surgery
involving CPB.
